Register
Login:
Share:
Email Facebook Twitter

Stock Market news at lse.co.uk - RSS News Feeds

Immupharma Share News (IMM)



Share News for Immupharma (IMM)


Share Price: 54.00Bid: 53.00Ask: 55.00Change: -3.00 (-5.26%)Faller - Immupharma
Spread: 2.00Spread as %: 3.77%Open: 57.50High: 57.50Low: 52.75Yesterday’s Close: 57.00






BRIEF-RESEARCH ALERT-Peel hunt starts Immupharma with sell

March 12 (Reuters) - ImmuPharma PLC: * Peel hunt starts Immupharma with sell For a summary of rating actions and price target changes on Eu
[12 Mar '12]

BRIEF-RESEARCH ALERT-Merchant Securities starts Immupharma with buy

Nov 21 (Reuters) - ImmuPharma PLC: * Merchant Securities starts Immupharma Plc with a buy rating For a summary of rating ac
[21 Nov '11]

BRIEF-Immupharma gets FDA approval to start phase III for Lupus drug

LONDON, Nov 3 (Reuters) - ImmuPharma PLC: * Lupuzor(TM) granted approval to start phase III and fast track designation by the FDA
[3 Nov '11]

BRIEF-Immupharma gets FDA approval to start phase III for Lupus drug

LONDON, Nov 3 (Reuters) - ImmuPharma PLC: * Lupuzor(TM) granted approval to start phase III and fast track designation by the FDA
[3 Nov '11]

UPDATE 1-ImmuPharma shares hit as Cephalon hands back drug

LONDON, Oct 21 (Reuters) - U.S. drugmaker Cephalon, which is being acquired by Teva, has handed back rights to lupus drug Lupuzor to ImmuPharma,
[21 Oct '11]

BRIEF-Immupharma regains Lupuzor rights from cephalon due to Teva merger

LONDON, Oct 21 (Reuters) - ImmuPharma PLC: * Regains Lupuzor rights from Cephalon due to Teva merger ((London Equities Newsroom; +44
[21 Oct '11]

BRIEF-Immupharma regains Lupuzor rights from cephalon due to Teva merger

LONDON, Oct 21 (Reuters) - ImmuPharma PLC: * Regains Lupuzor rights from Cephalon due to Teva merger ((London Equities Newsroom; +44
[21 Oct '11]

BRIEF-RESEARCH ALERT-Singer Capital cuts Immupharma price target

Sept 6 (Reuters) - ImmuPharma PLC: * Singer Capital cuts Immupharma Plc price target to 85P from 154P For a summary of rating actions
[6 Sep '11]



Sign up for Live Prices
Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.